cagrilintide vs semaglutide In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintide–semaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results Trial Scorecard: REDEFINE 1 and
Trial Scorecard: REDEFINE 1 and 2 Combined GLP 1 amylin analog bests monotherapy for HbA1c drop, weight loss in diabetes Cagrilintide and semaglutide act individually on both EI and EE a, Download Scientific Diagram Weight Loss Efficacy of Cagrilintide and Semaglutide gutsandgrowth Cagrilintide and semaglutide together drive record weight loss in global trial Cagrilintide + Semaglutide Blend Biotech Compounds
Pay in 4 interest-free payments of $5.15 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4




